New trial data shows that Pfizer’s updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday. The findings are reassuring, since human data on the tweaked vaccine was not available when the U.S. Food and Drug Administration approved the reformulated booster shots in September. “These early data… read on > read on >



















